Nanjing Vishee Medical Technology Co., Ltd (688580.SS)
CNY 31.76
(-4.31%)
CNY 31.76
(-4.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 134.19 Million | 86.16 Million | 157.36 Million | 120.76 Million | 141.47 Million | 85.84 Million |
| Net Income | 136.25 Million | 93.82 Million | 177.53 Million | 143.13 Million | 98.89 Million | 62.72 Million |
| Depreciation & Amortization | 20.13 Million | 17.14 Million | 11.08 Million | 8.79 Million | 7.95 Million | 3.81 Million |
| Deferred income taxes | -7.25 Million | 2.33 Million | -8.09 Million | -1.05 Million | -439.45 Thousand | 1.06 Million |
| Stock-based compensation | 19.65 Million | -2.82 Million | 21.37 Million | - | - | - |
| Change in working capital | -37.58 Million | -8.67 Million | -33.53 Million | -19.08 Million | 37.79 Million | 21.76 Million |
| Other non-cash items | 3.16 Million | -15.63 Million | -10.99 Million | -12.07 Million | -3.16 Million | -2.46 Million |
| Investing Cash Flow | -164.1 Million | -104.79 Million | -76.78 Million | 1.85 Million | -16.9 Million | -37.54 Million |
| Investments in PPE | -133.48 Million | -95.61 Million | -87.34 Million | -11.65 Million | -21.22 Million | -40.9 Million |
| Acquisitions | -20.1 Million | -34.19 Million | - | 11.73 Million | 21.22 Million | - |
| Investment purchases | -2.54 Billion | -3.64 Billion | -4.26 Billion | -2.1 Billion | -1.19 Billion | -781.5 Million |
| Sales/Maturities of investments | 2.53 Billion | 3.66 Billion | 4.28 Billion | 2.11 Billion | 1.19 Billion | 784.85 Million |
| Other Investing Activities | 1.9 Million | 9 Million | -9.99 Million | -11.65 Million | -21.22 Million | 776.46 |
| Financing Cash Flow | -63.96 Million | -95.01 Million | -80.99 Million | 994.75 Million | -42.44 Million | -21.49 Million |
| Debt repayment | -11.57 Million | -2.02 Million | -1.34 Million | -14 Million | -5.5 Million | -500 Thousand |
| Dividends payments | -51.03 Million | -88.9 Million | -71.83 Million | -49.85 Million | -37.82 Million | -20.99 Million |
| Common Stock Repurchased | -11.57 Million | -14.87 Million | 1.61 Million | 18.04 Million | - | - |
| Common Stock Issuance | - | 16.89 Million | -265.81 Thousand | -18.04 Million | - | - |
| Other Financing Activities | -12.92 Million | -6.1 Million | -9.15 Million | 1.05 Billion | -2.35 Million | 2389.05 |
| Accounts receivables | -21.76 Million | 7.31 Million | -13.14 Million | -15.9 Million | -2.47 Million | -270.9 Thousand |
| Accounts payables | -3.48 Million | -20.12 Million | -18.96 Million | 3.44 Million | 52.27 Million | 26.75 Million |
| Inventory | -5.08 Million | 1.8 Million | 6.66 Million | -5.57 Million | -11.56 Million | -5.79 Million |
| Other working capital | 19.65 Million | 2.33 Million | -8.09 Million | -1.05 Million | -439.46 Thousand | 27.55 Million |
| Cash at beginning of period | 1.24 Billion | 1.36 Billion | 1.36 Billion | 244.35 Million | 162.23 Million | 135.42 Million |
| Cash at end of period | 1.15 Billion | 1.24 Billion | 1.36 Billion | 1.36 Billion | 244.35 Million | 162.23 Million |
| Capital Expenditure | -133.48 Million | -95.61 Million | -87.34 Million | -11.65 Million | -21.22 Million | -40.9 Million |
| Effect of forex changes on cash | - | 0.86 | - | - | 1.00 | -0.50 |
| Net cash flow / Change in cash | -93.87 Million | -113.64 Million | -412.84 Thousand | 1.11 Billion | 82.12 Million | 26.8 Million |
| Free Cash Flow | 716.43 Thousand | -9.44 Million | 70.02 Million | 109.11 Million | 120.24 Million | 44.94 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 28.54 Million | 27.86 Million | 21.75 Million | 136.25 Million | 34.74 Million | 31.12 Million |
| Depreciation & Amortization | - | 6.04 Million | 6.04 Million | 20.13 Million | 20.13 Million | -9.83 Million |
| Deferred income taxes | - | - | - | -7.25 Million | - | -7.48 Million |
| Stock-based compensation | - | 11.13 Million | - | 19.65 Million | 19.65 Million | -3.02 Million |
| Change in working capital | - | -549.22 Thousand | - | -37.58 Million | -7.19 Million | 20.34 Million |
| Other non-cash items | 4.31 Million | 4.8 Million | -11.23 Million | 3.16 Million | -34.74 Million | 1.51 Million |
| Investing Cash Flow | -429.83 Million | -17.3 Million | -44.16 Million | -164.1 Million | -26.95 Million | -39 Million |
| Investments in PPE | -33.06 Million | -17.82 Million | -45.3 Million | -133.48 Million | -30.39 Million | -36.09 Million |
| Acquisitions | - | 16.53 Thousand | - | -20.1 Million | - | -5.4 Million |
| Investment purchases | -1.15 Billion | -858 Million | -274 Million | -2.54 Billion | -724 Million | -482 Million |
| Sales/Maturities of investments | 757.23 Million | 858 Million | 275.13 Million | 2.53 Billion | 727.43 Million | 484.1 Million |
| Other Investing Activities | - | 500 Thousand | 1.13 Million | 1.9 Million | 3.43 Million | 400 Thousand |
| Financing Cash Flow | -17.1 Thousand | -96.35 Million | -6.7 Million | -63.96 Million | -10.55 Million | -3.92 Million |
| Debt repayment | - | - | - | -11.57 Million | - | - |
| Dividends payments | -5274.14 | -102.19 Million | - | -51.03 Million | -4.12 Million | -2.64 Million |
| Common Stock Repurchased | 11.7 Million | -11.7 Million | - | -11.57 Million | -11.57 Million | 5.15 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -22.37 Thousand | -84.65 Million | -6.7 Million | -12.92 Million | -6.43 Million | -6.44 Million |
| Accounts receivables | - | -7.08 Million | - | -21.76 Million | -21.76 Million | 13.27 Million |
| Accounts payables | - | - | - | -3.48 Million | - | 3.02 Million |
| Inventory | - | -4.59 Million | - | -5.08 Million | -5.08 Million | 7.07 Million |
| Other working capital | - | 11.13 Million | - | 19.65 Million | 19.65 Million | -3.02 Million |
| Cash at beginning of period | 1.02 Billion | 1.11 Billion | 1.15 Billion | 1.24 Billion | 1.12 Billion | 1.14 Billion |
| Cash at end of period | 625.06 Million | 1.02 Billion | 1.11 Billion | 1.15 Billion | 1.15 Billion | 1.12 Billion |
| Capital Expenditure | -33.06 Million | -17.82 Million | -45.3 Million | -133.48 Million | -30.39 Million | -36.09 Million |
| Effect of forex changes on cash | - | - | - | - | - | -2.1 Million |
| Net cash flow / Change in cash | -400.22 Million | -86.84 Million | -41.48 Million | -93.87 Million | 25.14 Million | -12.38 Million |
| Free Cash Flow | -204.83 Thousand | 8.8 Million | -34.78 Million | 716.43 Thousand | 32.26 Million | -3.45 Million |
7976
BZLFY
RGL
003036
YASKY
THE